Skip to Main Content

Paper Details

Balancing Expediency and Scientific Rigor in Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Development.
J Infect Dis
9
2020
Coronavirus 2, Severe Acute Respiratory Syndrome Coronavirus
Animals, Antibodies, Neutralizing, Antibodies, Viral, Antibody-Dependent Enhancement, Betacoronavirus, COVID-19, COVID-19 Vaccines, Clinical Trials as Topic, Coronavirus Infections, Humans, Immunogenicity, Vaccine, Pandemics, Pneumonia, Viral, SARS-CoV-2, Viral Vaccines
Author NameAffiliation
Kevin W GraepelVanderbilt University School of Medicine
Sonali Kochhar
Sonali KochharUniversity of Washington
E ClaytonVanderbilt University Medical Center
E ClaytonCenter for Biomedical Ethics and Society and Department of Health Policy, Vanderbilt University School of Medicine
E ClaytonVanderbilt University Law School
Kathryn M EdwardsVanderbilt University Medical Center
  • 1 - 7

Datasets

Release 1.2